- About Us
- Our Clients
- Valuation & Transactions
- Strategy & Advisory
- Coding & Compliance
- Healthcare Sectors
- Ambulatory Surgery Centers
- Behavioral Health
- Hospital-Based Medicine
- Imaging & Radiology
- Medical Device & Life Sciences
- Medical Transport
- Physician Practices
- Post-Acute Care
- Risk-Bearing Organizations & Health Plans
- Telehealth & Healthcare IT
- Urgent Care & Free Standing EDs
- Contact Us
This annual report examines healthcare M&A trends and gives a 2022 outlook.
Healthcare mergers and acquisition activity returned in full force in 2021 amidst a broad economic recovery, even as the healthcare industry continued to respond to the evolving COVID-19 pandemic. In 2021, healthcare M&A volume and value both exceeded pre-pandemic levels. The main catalyst for transactions continued to be a focus on building scale and cost efficiencies. Insatiable demand and limited supply of acquisition targets drove healthcare deal multiples to the highest levels seen in decades. As of the writing of this report, macroeconomic factors have impacted the economic recovery that fed deal volume and values in 2021.
Leveraging VMG Health’s expertise as the leading provider of healthcare transaction and strategy services, this annual report examines the healthcare M&A landscape in 2021 and the 2022 outlook. We analyze transaction activity, regulatory changes, reimbursement outlook, M&A outlook, and other industry dynamics driving M&A across several prominent healthcare verticals.
Download VMG Health’s 2022 Healthcare M&A Report
Analyzing transaction activity, regulatory changes, reimbursement outlook, M&A outlook, and other industry dynamics driving M&A across several prominent healthcare verticals.
VMG Health's 2022 Healthcare M&A Report